Protocol No.
156598 (S2015)
Principal Investigator
Hyngstrom, John
Phase
III
Age Group
Adult
ClinicalTrials.Gov
NCT03860883 (Click to jump to clinicaltrials.gov)
Title
Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
Objective
Applicable Disease Sites
Melanoma
Participating Institutions
Huntsman Cancer Institute
Status
Open
Clinical trials search powered by Forte Research Systems